Roger McIntyre, MD, FRCPC

Enhancing the Treatment of MDD Through an Interprofessional Educational Activity

Introduction: The goal of this interprofessional continuing education (IPCE) activity was to enhance the treatment of major depressive disorder (MDD) using patient cases.

Jess Dropkin ;

Roger McIntyre , MD, FRCPC;

Jovana Lubarda , PhD;

Marcello Morgan , MD, MPH;

03/01/2019

Success of CME at Improving Physicians’ Knowledge of LAIs for Bipolar Disorder

Introduction: We sought to determine whether continuing medical education (CME) improves knowledge regarding bipolar disorder (BPD) and its treatment with the use of long acting injectabl...

Jovana Lubarda , PhD;

Marcello Morgan , MD, MPH;

Leslie Citrome , MD;

Roger McIntyre , MD, FRCPC;

Piyali Chatterjee-Shin ;

03/01/2019

Effects of Long-Term Valbenazine on Psychiatric Status in Patients With Tardive Dyskinesia and a Primary Mood Disorder

Objective: In two long-term phase 3 studies, sustained TD improvements were observed in participants who received once-daily treatment with valbenazine (40 or 80 mg). Data from these stud...

Joshua Burke , MS;

Scott Siegert , PharmD;

Gary Remington , MD, PhD;

Rachel Weber , PhD;

Leslie Lundt , MD;

Khodayar Farahmand , PharmD;

Christoph U. Correll , MD;

Roger McIntyre , MD, FRCPC;

03/01/2019

Interview

Quantifying the Consequences of Misdiagnosing Bipolar I Disorder

07/26/2023

Roger McIntyre , MD, FRCPC;

Roger McIntyre, MD, FRCPC, professor of psychiatry and pharmacology, University of Toronto, and head, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, shares how real-world data reveals the gravity of misdiagnosing...

Roger McIntyre, MD, FRCPC,...

07/26/2023

Veterans Health Today

Q&As

Bipolar Disorder Treatment Challenges: Diagnoses, Comorbidities, and Polypharmacy

02/02/2024

Roger McIntyre , MD, FRCPC;

Roger McIntyre, MD, FRCPC, professor of psychiatry and pharmacology, University of Toronto, offers insight into some of the challenges associated with diagnosing and treating bipolar disorder.

Roger McIntyre, MD, FRCPC,...

02/02/2024

Psych Congress Network

Validation of a Mobile Application Version of the Cognition Kit Digit Symbol Substitution Test in Patients With Major Depressive Disorder

Objective: The primary objective of this study was to evaluate the convergent validity of the Cognition Kit Digit Symbol Substitution Test (DSST) mobile app among patients with major depr...

Maggie McCue , MS, RD;

Ben Fehnert , MA;

Orly Lipsitz , BSc;

Mehala Subramaniapillai , BSc(Hons), MSc;

Nelson Rodrigues , MS;

Roger McIntyre , MD, FRCPC;

Lambros Chrones , MD;

James King , MA;

Sharif Uddin , MS;

Kevin Kratiuk , BS;

Joshua Rosenblat , MD, MSc, FRCPC;

Rodrigo Masur , MD, PhD;

10/08/2020

The Rapid Mood Screener: A Novel and Pragmatic Screener Tool for Bipolar I Disorder

Introduction: Depressive episodes/symptoms of bipolar I disorder (BPD-I) are commonly misdiagnosed as major depressive disorder (MDD). We developed the novel and pragmatic Rapid Mood Scre...

Patrick Gillard , PharmD, MS;

Amanda Harrington , PhD;

Kate Sullivan , APN, RN;

Lauren Nelson , PhD;

Roger McIntyre , MD, FRCPC;

Susan McElroy , MD;

Rakesh Jain , MD, MPH, RD;

Charles Brendan Montano , MD;

Mehul Patel , MD, PharmD;

T. Michelle Brown , PhD;

Prakash M. Masand , MD;

10/08/2020

Patient-Reported Effects of Adjunctive Brexpiprazole on Calming and Engagement in Major Depressive Disorder: Post Hoc Analysis of Clinical Trial Exit Interviews

Background: Calming patients (without sedation) and increasing engagement (without overactivation) are important components of the successful treatment of major depressive disorder (MDD)....

Catherine Weiss , PhD;

Stine Rasmussen Meehan , PhD;

Catherine Gupta , PhD;

Michael Thase , MD;

Zahinoor Ismail , MD;

Roger McIntyre , MD, FRCPC;

T. Michelle Brown , PhD;

10/08/2020

Efficacy of Adjunctive Brexpiprazole in Adults With MDD: Improvement of Patient Engagement Based on Selected Items From the Inventory of Depressive Symptomatology Self-Report (IDS-SR) Scale

Objective: These post-hoc analyses used relevant items from the IDS-SR to explore whether treatment with adjunctive brexpiprazole in patients with MDD has potential to improve a new conce...

Anne Pedersen , MSc;

Klaus Groes Larsen , PhD;

Anna-Greta Nylander , PhD;

Catherine Weiss , PhD;

Stine Rasmussen Meehan , PhD;

Michael Thase , MD;

Zahinoor Ismail , MD;

Dalei Chen , PhD;

Ross Baker , PhD, MBA;

Roger McIntyre , MD, FRCPC;

11/22/2019

Lumateperone in the Treatment of Schizophrenia: Efficacy in Demographic and Clinical Subgroups

Introduction: Patients with schizophrenia are a heterogenous population and understanding which factors may influence antipsychotic efficacy is important in improving outcomes. Lumatepero...

Sharon Mates , PhD;

Kimberly Vanover , PhD;

Ian D'Souza , PhD;

Roger McIntyre , MD, FRCPC;

Suresh Durgam , MD;

Robert Davis , PhD;

Andrew Satlin , MD;

11/22/2019